Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 22,491 | 23,014 | 20,360 | 19,495 | 18,953 |
| Operating Income | -22,491 | -23,014 | -20,360 | -19,495 | -18,953 |
| Interest Expense | 0 | 93 | 210 | 671 | 0 |
| Other Income | -181 | 0 | 0 | -458 | -241 |
| Pre-tax Income | -22,672 | -23,107 | -20,570 | -20,624 | -19,194 |
| Net Income Continuous | -22,672 | -23,107 | -20,570 | -20,624 | -19,194 |
| Net Income | $-22,672 | $-23,107 | $-20,570 | $-20,624 | $-19,194 |
| EPS Basic Total Ops | -0.63 | -0.74 | -0.70 | -0.69 | -0.66 |
| EPS Basic Continuous Ops | -0.63 | -0.74 | -0.70 | -0.69 | -0.66 |
| EPS Diluted Total Ops | -0.63 | -0.74 | -0.70 | -0.69 | -0.66 |
| EPS Diluted Continuous Ops | -0.63 | -0.74 | -0.70 | -0.69 | -0.66 |
| EBITDA(a) | $-22,158 | $-22,689 | $-20,057 | $-19,158 | $-18,659 |